Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Dementia01:30

Dementia

96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
96

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DOACs vs Warfarin for Post-myocardial Infarction Left Ventricular Thrombus: A GRADE-assessed Meta-Analysis With Trial Sequential Analysis of Randomized Trials.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same author

Albumin-to-creatinine ratio as non-invasive marker for prediction of non- bleeding esophageal varices. a cross-sectional observational study.

BMC gastroenterology·2026
Same author

MBAS2024: A large-scale benchmark for multi-class bi-atrial segmentation in multi-center contrast-enhanced MRIs.

Medical image analysis·2026
Same author

Logits -with-correlation-based distillation for class incremental learning with limited initial classes.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Specifically targeted engineered exosomes loaded with circAKR1A1 enhance tumorigenesis and metastasis in prostate cancer by activating the PI3K/Akt signalling pathway.

Oncogene·2026
Same author

Mechanical Circulatory Support During Ventricular Tachycardia Ablation: A Systematic Review and Meta-Analysis of Procedural and Clinical Outcomes.

Journal of cardiovascular electrophysiology·2026

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

957

Multi-scale multimodal deep learning framework for Alzheimer's disease diagnosis.

Mohammed Abdelaziz1, Tianfu Wang2, Waqas Anwaar3

  • 1National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Health Science Center, Shenzhen University, Shenzhen, 518060, China; Department of Communications and Electronics, Delta Higher Institute for Engineering and Technology (DHIET), Mansoura, 35516, Egypt.

Computers in Biology and Medicine
|November 23, 2024
PubMed
Summary

This study introduces a novel deep learning model for Alzheimer's disease (AD) diagnosis using multimodal neuroimaging. The model effectively integrates multi-scale magnetic resonance imaging (MRI) and positron emission tomography (PET) data, outperforming existing methods.

Keywords:
Alzheimer's diseaseConvolutional neural networkMulti-scale representationMultimodal data

More Related Videos

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.9K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

110

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

957
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.9K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

110

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Multimodal neuroimaging (MRI/PET) offers complementary brain insights for Alzheimer's disease (AD) diagnosis.
  • Current deep learning models often use suboptimal patch-based extraction and simple data concatenation, neglecting multi-scale features and inter-modal interactions.
  • This limits their ability to capture diverse structural changes and identify discriminative regions crucial for accurate AD diagnosis.

Purpose of the Study:

  • To develop an advanced multimodal and multi-scale deep learning model for improved Alzheimer's disease diagnosis.
  • To effectively leverage the interactions within and between different scales of neuroimaging data.
  • To enhance feature extraction and fusion for better discrimination of AD stages.

Main Methods:

  • Utilized convolutional neural networks (CNNs) to embed multi-scale MRI and PET images.
  • Developed multimodal scale fusion mechanisms employing multi-head self-attention and cross-attention to capture global relations and inter-modal contributions.
  • Integrated a cross-modality fusion module with multi-head cross-attention to combine MRI and PET data across scales, promoting global feature enhancement.

Main Results:

  • The proposed model demonstrated superior performance in discriminating between different stages of Alzheimer's disease on the ADNI dataset.
  • Achieved better diagnostic accuracy compared to existing state-of-the-art deep learning methods.
  • Effectively captured complex interactions between multimodal and multi-scale neuroimaging features.

Conclusions:

  • The developed multimodal and multi-scale deep learning approach significantly enhances Alzheimer's disease diagnosis.
  • Integrating multi-scale features and inter-modal interactions via attention mechanisms is crucial for improving diagnostic accuracy.
  • This model offers a promising advancement in leveraging neuroimaging data for AD detection and staging.